Skip to main content

2 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

MorphoSys and Heptares explore new targets

Friday 8 March 2013

Interviewee/Contributor

Malcolm Weir

Organisation

Heptares Therapeutics Ltd

Organisations

Eagle Genomics Ltd
Horizon Discovery Group Ltd
BioTop
University of Pennsylvania, Perelman School of Medicine
Vivoryon Therapeutics AG
Imanova Ltd
Novartis Pharmaceuticals
BDO UK LLP
Oryx GmbH & Co KG and Valo Therapeutics Ltd
SFL Regulatory Affairs & Scientific Communication

Interviewees and Contributers

Will James
Ali Mortazavi
John Mayo
Paul Kemp
Oumeya Adjali
Steffen Thirstrup
Clare Ozawa
Klaus Breiner
Nicole Faust
Chantal van Gils

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form